These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 19340355)
1. Acetylcholine-regulated K+ current remodelling in the atrium after myocardial infarction and valsartan administration. Zhao QY; Huang CX; Jiang H; Okello E; Wang X; Tang YH; Li GS Can J Cardiol; 2009 Apr; 25(4):e115-8. PubMed ID: 19340355 [TBL] [Abstract][Full Text] [Related]
2. The effects of cilazapril and valsartan on the mRNA and protein expressions of atrial calpains and atrial structural remodeling in atrial fibrillation dogs. Li Y; Li WM; Gong YT; Li BX; Liu W; Han W; Dong D; Sheng L; Xue JY; Zhang L; Chu S; Yang BF Basic Res Cardiol; 2007 May; 102(3):245-56. PubMed ID: 17268887 [TBL] [Abstract][Full Text] [Related]
3. Effect of vagal stimulation and differential densities of M2 receptor and IK,ACh in canine atria. Zhao QY; Huang CX; Liang JJ; Chen H; Yang B; Jiang H; Li GS Int J Cardiol; 2008 Jun; 126(3):352-8. PubMed ID: 17590455 [TBL] [Abstract][Full Text] [Related]
4. Differential densities of muscarinic acetylcholine receptor and I(K,ACh) in canine supraventricular tissues and the effect of amiodarone on cholinergic atrial fibrillation and I(K,ACh). Huang CX; Zhao QY; Liang JJ; Chen H; Yang B; Jiang H; Li GS Cardiology; 2006; 106(1):36-43. PubMed ID: 16612067 [TBL] [Abstract][Full Text] [Related]
5. Aliskiren in combination with valsartan exerts synergistic protective effects against ventricular remodeling after myocardial infarction in mice. Higashikuni Y; Takaoka M; Iwata H; Tanaka K; Hirata Y; Nagai R; Sata M Hypertens Res; 2012 Jan; 35(1):62-9. PubMed ID: 21833001 [TBL] [Abstract][Full Text] [Related]
6. [On angiotensin II receptor distribution after myocardial infarction in dogs]. Qu XF; Li JJ; Xi Y; Shen JX; Xiu CH; Yue L; Wang GZ; Huang YL Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Apr; 37(4):358-62. PubMed ID: 19791474 [TBL] [Abstract][Full Text] [Related]
7. Sacubitril/valsartan attenuates atrial electrical and structural remodelling in a rabbit model of atrial fibrillation. Li LY; Lou Q; Liu GZ; Lv JC; Yun FX; Li TK; Yang W; Zhao HY; Zhang L; Bai N; Zhan CC; Yu J; Zang YX; Li WM Eur J Pharmacol; 2020 Aug; 881():173120. PubMed ID: 32325147 [TBL] [Abstract][Full Text] [Related]
8. Human inward rectifier potassium channels in chronic and postoperative atrial fibrillation. Dobrev D; Wettwer E; Kortner A; Knaut M; Schüler S; Ravens U Cardiovasc Res; 2002 May; 54(2):397-404. PubMed ID: 12062344 [TBL] [Abstract][Full Text] [Related]
9. Effects of valsartan on ventricular arrhythmia induced by programmed electrical stimulation in rats with myocardial infarction. Jiao KL; Li YG; Zhang PP; Chen RH; Yu Y J Cell Mol Med; 2012 Jun; 16(6):1342-51. PubMed ID: 22128836 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of IK,ACh current may contribute to clinical efficacy of class I and class III antiarrhythmic drugs in patients with atrial fibrillation. Voigt N; Rozmaritsa N; Trausch A; Zimniak T; Christ T; Wettwer E; Matschke K; Dobrev D; Ravens U Naunyn Schmiedebergs Arch Pharmacol; 2010 Mar; 381(3):251-9. PubMed ID: 19760273 [TBL] [Abstract][Full Text] [Related]
11. Valsartan and coronary haemodynamics in early post-myocardial infarction in rats. Gervais M; Richer C; Fornes P; De Gasparo M; Giudicelli JF Fundam Clin Pharmacol; 1999; 13(6):635-45. PubMed ID: 10626750 [TBL] [Abstract][Full Text] [Related]
12. Relationship between K+ channel down-regulation and [Ca2+]i in rat ventricular myocytes following myocardial infarction. Kaprielian R; Wickenden AD; Kassiri Z; Parker TG; Liu PP; Backx PH J Physiol; 1999 May; 517 ( Pt 1)(Pt 1):229-45. PubMed ID: 10226162 [TBL] [Abstract][Full Text] [Related]
13. Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions. Burchill LJ; Velkoska E; Dean RG; Griggs K; Patel SK; Burrell LM Clin Sci (Lond); 2012 Dec; 123(11):649-58. PubMed ID: 22715807 [TBL] [Abstract][Full Text] [Related]
14. Decreased ATP-sensitive K(+) current density during chronic human atrial fibrillation. Balana B; Dobrev D; Wettwer E; Christ T; Knaut M; Ravens U J Mol Cell Cardiol; 2003 Dec; 35(12):1399-405. PubMed ID: 14654366 [TBL] [Abstract][Full Text] [Related]
15. Endothelin-1 mediated inhibition of the acetylcholine-activated potassium current from rabbit isolated atrial cardiomyocytes. Spiers JP; Kelso EJ; McDermott BJ; Scholfield CN; Silke B Br J Pharmacol; 1996 Dec; 119(7):1427-37. PubMed ID: 8968552 [TBL] [Abstract][Full Text] [Related]
16. [Angiotensin II activates large-conductance Ca(2+)-activated potassium channels in human mesenteric artery smooth muscle cells]. Wen J; Cheng J; Li PY; Mao L; Yue XL; Li C; Yang Y Sheng Li Xue Bao; 2013 Feb; 65(1):39-46. PubMed ID: 23426512 [TBL] [Abstract][Full Text] [Related]
17. Valsartan therapy in heart failure after myocardial infarction: the role of endothelial dependent vasorelaxation. Thai H; Guarraia D; Johnson N; Goldman S; Gaballa MA J Cardiovasc Pharmacol; 2007 Dec; 50(6):703-7. PubMed ID: 18091589 [TBL] [Abstract][Full Text] [Related]
18. Myocardial infarction and atrial fibrillation: importance of atrial ischemia. Alasady M; Shipp NJ; Brooks AG; Lim HS; Lau DH; Barlow D; Kuklik P; Worthley MI; Roberts-Thomson KC; Saint DA; Abhayaratna W; Sanders P Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):738-45. PubMed ID: 23873140 [TBL] [Abstract][Full Text] [Related]
19. Upregulation of angiotensin II type 2 receptor and limitation of myocardial stunning by angiotensin II type 1 receptor blockers during reperfused myocardial infarction in the rat. Jugdutt BI; Menon V J Cardiovasc Pharmacol Ther; 2003 Sep; 8(3):217-26. PubMed ID: 14506547 [TBL] [Abstract][Full Text] [Related]
20. Blockade of angiotensin II type 1 receptors suppressed free radical production and preserved coronary endothelial function in the rabbit heart after myocardial infarction. Kuno A; Miura T; Tsuchida A; Hasegawa T; Miki T; Nishino Y; Shimamoto K J Cardiovasc Pharmacol; 2002 Jan; 39(1):49-57. PubMed ID: 11743227 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]